2021, Number 3
<< Back Next >>
Rev Cubana Cardiol Cir Cardiovasc 2021; 27 (3)
Sudden arrhythmogenic death in subjects without demonstrable structural heart disease by conventional methods
Dorantes SM, Cruz CM, Castro HJ, Castañeda CO, Martínez LF, Falcón RR, de Zayas GJ, Mengana BA, de la Vega VK
Language: Spanish
References: 46
Page: 1-8
PDF size: 726.04 Kb.
ABSTRACT
Introduction: Arrhythmogenic sudden cardiac death in subjects without structural heart disease demonstrable by conventional methods is a major clinical and public health conflict for the international cardiology community.
Objective: Characterize patients with apparently normal hearts, resuscitated from episodes of arrhythmogenic sudden death.
Method: During 20 years (2000-2020), the National Registry of 138 patients with an apparent normal heart, resuscitated from episodes of arrhythmogenic sudden death and admitted to the Arrhythmia and Cardiac Pacing Service, was carried out for study, diagnosis and treatment.
Results: The most common electrical entity was idiopathic ventricular fibrillation (29.7%, a diagnosis that may change over time as evidence of a specific subpopulation appears); followed by Brugada syndrome (22.5%). 73.2% corresponded to channelopathies as a whole. The arrhythmia causing death was ventricular fibrillation (43.8%), followed by tip torsion (14.7%). There were recurrences in 76.1%, which requires prompt therapeutic measures. Premonitory electrical signs were frequent (74.6%), neither absolute nor negligible. Electrical stimulation was performed in 50 patients, only in 10 (20%) it was possible to induce arrhythmia (low frequency compared to other series, we have no explanation for it because the protocols were similar), the therapeutic decision was not based solely on in this studio.
Conclution: Idiopathic ventricular fibrillation and Brugada and long QT syndromes are the most frequent electrical entities in these patients, and ventricular fibrillation the arrhythmia responsible for sudden death in most cases. Relapses and predictive electrical signs are very common; electrical stimulation has value although there are false positives and negatives and alone should not decide the therapeutic conduct.
REFERENCES
Zipes DP, Wellens HJJ. Sudden cardiac death. Circulation 1998;98(21):2334-51.
Luscher TF. Sudden cardiac death: addressing unresolved issues. Eur Heart J 2020;41(21):1947-51.
Estes NAM III. Sudden cardiac arrest from primary electrical diseases provoking concealed arrhythmogenic syndromes. Circulation 2005;112(15):2220-1.
Haissaguerre M, Nademanee K, Hocini M, Cheniti G, Duchateau J, Frontera A et al. Depolarization versus repolarization abnormality underlying inferolateral J- wave syndromes: new concepts in sudden cardiac death with apparently normal hearts. Heart Rhythm 2019;16(5):781-90.
Dorantes M, Castro J, Castaneda O. Papel del sistema Purkinje y del tracto de salida del ventrículo derecho en las arritmias ventriculares malignas y la muerte súbita. CorSalud 2020;12(1):77-84.
Chugh SS, Kelly KL, Titus JL. Sudden cardiac death with apparently normal heart. Circulation 2000;102(6):649-54.
Priori SG, Aliot E, Blomstrom-Ludqvist C, Bossaert L, Breithardt G, Brugada P et al. Task Force on Sudden Cardiac Death of the European Society of Cardiology. Eur Heart J 2001;22(16):1374-450.
Goldberger JJ, Buxton AE, Cain M, Costantini O, Exner DV, Knight BP et al. Risk stratification for arrhythmic sudden cardiac death: identifying the roadblocks. Circulation 2011;123(21):2423-30.
Sawhney N, Narayan SM. Sudden cardiac arrest in patients with preserved left ventricular systolic function: a clinical dilemma. Heart Rhythm 2009;6 (suppl 3):S15-S21.
Spector PS. Diagnosis and management of sudden cardiac death. Heart 2009;91(3):408-13
Koplan BA, Stevenson WG. Sudden arrhythmic death syndrome. Heart 2007;93(5):547-8.
Conte G, Belhassen B,Lambiase P, Ciconte G, Asmundio C, Arbelo E et al. Out-of-hospital cardiac arrest due to idiopathic ventricular fibrillation in patients with normal electrocardiograms: results from a multicentre long-term registry. Europace 2019;21(11):1670-7.
Dorantes M, López A. Fibrilación ventricular: la arritmia más desafiante. Parte I. Rev Cubana Cardiol Cir Cardiovasc 2011;17(1):45-51.
14.Dorantes M, López A. Fibrilación ventricular idiopática: un diagnóstico deslizante. Parte II. Rev Cubana Cardiol Cir Cardiovasc 2011;17(3):209-17.
Tabereaux PB, Dosdall DJ, Ideker RE. Mechanisms of ventricular fibrillation maintenance: wandering wavelets, mother rotors or foci. Heart Rhythm 2009;6(3):405-15.
Ideker RE, Rogers JM. Human ventricular fibrillation. Wandering wavelets, mother rotors or both? Circulation 2006;114(6):530-2.
Ideker RE, Rogers J, Huang J. Types of ventricular fibrillation: 1,2,4,5 or 300000? J Cardiovasc Electrophysiol 2004;15(12):1441-3.
Vaquero M, Calvo D, Jalife J. Cardiac fibrillation: from ion channels to rotors in the human heart. Heart Rhythm 2008;5(6):872-9.
Anderson RD, Kumar S, Kalman JM, Sanders P, Sacher F, Hocini M et al. Catheter ablation of ventricular fibrillation. Heart, Lung and Circulation 2019;28(1):110-22.
Lindsay BD. Eliminating triggers of ventricular fibrillation: the past, present, and future. J Am Coll Cardiol 2009;54(6):529-30.
Dorantes M, Ponce EF. Extrasístoles ventriculares con intervalo corto de acoplamiento: su trascendencia. CorSalud 2015;7(4):253-7.
Dorantes M, Ponce E, Falcón R. Extrasístoles ventriculares con intervalo corto de acoplamiento como detonantes de arritmias malignas. CorSalud 2016;8(3):144-52.
Dorantes M. Despolarización y repolarización ventriculares para estratificar riesgo de arritmias ventriculares malignas y muerte súbita. CorSalud 2018;10(3):266-73.
Dorantes M. Signos eléctricos premonitorios de riesgo: ¿cuál es el mejor? Controversia no terminada en impetuoso crecimiento. CorSalud 2010;2(1):58-61.
Dorantes M, Trung CP. Estimulación eléctrica programada del corazón en el síndrome de Brugada. Parte II. Variaciones sobre un mismo tema. CorSalud 2015;7(3):202-13
Márquez MF, Cárdenas M. La controversia de la utilidad de la estimulación ventricular para la estratificación de riesgo en el síndrome de Brugada. CorSalud 2015;7(3):158-60.
Dorantes M, Trung CP. Estimulación eléctrica programada del corazón en el síndrome de Brugada. Parte I: visión actual. CorSalud 2015;7(1):46-51.
Martini M, Nava A, Thiene G, Buja GF, Canciani B, Scognamiglio R et al. Ventricular fibrillation without apparent structural heart disease. Am Heart J 1989;118(6):1203-9.
Martini B, Corrado D, Nava A. Syndrome of right bundle branch block, ST segment elevation and sudden death. Evidence of an organic susbstrate. En: Nava A, Rossi L, Thiene G eds. Arrhythmogenic right ventricular cardiomyopathy/dysplasia. Amsterdam Elsevier 1997 p 438-53.
Pappone C, Brugada J, Vicedomini G. Electrical substrate elimination in 135 consecutive patients with Brugada syndrome. Circ Arrhythm Electrophysiol 2017;10(5):e005053 doi:10.1161/CIRCP.117.005053
Haissaguerre M, Hocini M, Cheniti G, Duchateau J, Sacher F, Puyo S et al. Localized structural alterations underlying a subset of unexplained sudden cardiac death. Circ Arrhythm Electrophysiol 2018;11(17):e006120.
Martini B, Martini N, Dorantes M, Márquez M, Zhang L, Fontaine G et al. Pistas de una enfermedad orgánica subyacente en el síndrome de Brugada. Arch Cardiol Mex 2017;87(1):49-60.
Pieroni M, Notarstefano P, Oliva A, Campuzano O, Santangeli P, Coll M et al. Electroanatomic and pathologic right ventricular outflow tract abnormalities in patients with Brugada syndrome. J Am Coll Cardiol 2018;72(22):2747-57.
Frustaci A, Priori SG, Pieroni M, Chimenti C, Napolitano C, Rivolta I et al. Cardiac histological substrate in patients with clinical phenotype of Brugada syndrome. Circulation 2005;112(24):3680-7.
Arbelo E. Another piece of the puzzle: assessment of mechanical dispersion by magnetic resonance in long QT syndrome. Heart Rhythm 2017;14(9):1398-9.
Pappone C, Monasky MM, Micaglio E, Ciconte G. Right ventricular electromechanical abnormalities in Brugada syndrome: is this a cadiomyopathy? Eur Heart J 2020 22 (suppl E) E 101-E104.
Brugada J, Pappone C, Berruezo A,Vicedomini G, Manguso F, Ciconte G et al. Brugada syndrome phenotype elimination by epicardial substrate ablation Circ Arrhythm Electrophysiol 2015;8(6):1373-81.
De Ferrari GM, Schwartz PJ. Long QT syndrome, a purely electrical disease? Not anymore. Eur Heart J 2009;30(3):253-5.
Hoogenlijk MG, Opthof T, Postema PG, Wilde AAM, de Bakker JMT, Coronel R. The Brugada ECG pattern: a marker of channelopathy, structural heart disease, or neither? Toward a unifying mechanism of the Brugada syndrome. Circ Arrhythm Electrophysiol 2010;3(3):283-90.
Juang JMJ, Lin JL. Brugada syndrome: merely a ion channelopathy, a structural heart disease, or mixed? Heart Rhythm 2016;14(4):590-1.
Corrado D, Migliore F, Zorzi A. Brugada syndrome: in search of a cause. J Am Coll Cardiol 2018,72(22):2758-60.
Priori SG, Remme CA. Inherited conditions of arrhythmia: translating disease mechanisms to patient management. Cardivasc Res 2020;116(9):1539-41.
Nador F, Beria G, De Ferrari M, Stramba-Badiale M, Locati EH, Lotto A et al. Unsuspected echocardiographic abnormality in the long QT syndrome. Diagnostic, prognostic, and pathogenic implications. Circulation1991;84(4):1530-42.
Frea S, Giustetto C, Capriolo M, Scrocco C, Fornengo C, Benedetto S et al. New echocardiographic insights in short syndrome: more than a channelopathy? Heart Rhythm 2015;12(10):2096-2105.
Pieroni M, Notarstefano P, Ciabatti M, Nesti M, Martinese L, Liistro F et al. Electroanatomic mapping-guided endomyocardial biopsy in patients with apparently idiopathic ventricular arrhythmias. doi:10.1111/pace.14014
Conte G, Belhassen B, Lambiase P, Ciconte G, de Asmudis C, Arbelo E et al. Out-of-hospital cardiac arrest due to idiopathic ventricular fibrillation in patients with normal electrocardiograms: results from a multicentre long-term registry. Europace 2019;21:1670-7.